QRG Capital Management’s AbbVie ABBV Stock Holding History

QRG Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.7M	Buy	301,006 +24,245	+9%	+$5.22M	0.63%	25
2026 Q1	$60.2M	Buy	276,761 +33,079	+14%	+$7.34M	0.62%	24
2025 Q4	$55.7M	Buy	243,682 +18,026	+8%	+$4.11M	0.62%	23
2025 Q3	$52.2M	Sell	225,656 -75,094	-25%	-$15.3M	0.63%	23
2025 Q2	$55.8M	Buy	300,750 +9,145	+3%	+$1.7M	0.49%	32
2025 Q1	$61.1M	Sell	291,605 -1,002	-0.3%	-$195K	0.63%	23
2024 Q4	$52M	Buy	292,607 +1,912	+0.7%	+$352K	0.54%	32
2024 Q3	$57.4M	Buy	290,695 +13,319	+5%	+$2.49M	0.62%	26
2024 Q2	$47.6M	Buy	277,376 +7,642	+3%	+$1.27M	0.56%	28
2024 Q1	$49.1M	Buy	269,734 +3,809	+1%	+$656K	0.62%	30
2023 Q4	$41.2M	Buy	265,925 +10,183	+4%	+$1.48M	0.61%	29
2023 Q3	$38.1M	Buy	+255,742	New	+$37.5M	0.66%	26

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

QRG Capital Management's ABBV Position: Q2 2026 in Review

QRG Capital Management increased its AbbVie (ABBV) stake by 8.8% in Q2 2026, buying an estimated $5.22M and bringing the position to 301,006 shares worth $75.7M. The position accounts for 0.63% of the portfolio, ranked #25.

QRG Capital Management first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

QRG Capital Management held 301,006 shares of AbbVie worth $75.7M as of Q2 2026.
QRG Capital Management bought 24,245 AbbVie shares in Q2 2026, an estimated $5.22M.
AbbVie made up 0.63% of QRG Capital Management's portfolio in Q2 2026, its #25 holding.
QRG Capital Management first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.